Evidence map›Paper›PMID 32646486›Full record

ArticleGenome biology2020

Genes adapt to outsmart gene-targeting strategies in mutant mouse strains by skipping exons to reinitiate transcription and translation.

Vishnu Hosur, Benjamin E Low, Daniel Li, Grace A Stafford, Vivek Kohar, Leonard D Shultz, Michael V Wiles

Open access · goldAbstract readComparative Study
In one paragraph

Article in Genome biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Investigating the effects of a cryptic splice site in the En2 splice acceptor sequence used in the IKMC knockout-first alleles.Mammalian genome : official journal of the International Mammalian Genome Society · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Inactive rhomboid proteins RHBDF1 and RHBDF2 (iRhoms): a decade of research in murine models.Mammalian genome : official journal of the International Mammalian Genome Society · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vishnu HosurThe Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA. vishnu.hosur@jax.org.ORCID 0000-0003-2084-1723
Benjamin E LowThe Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA.
Daniel LiArthritis and Tissue Degeneration Program, Hospital for Special Surgery at Weill Cornell Medicine, New York, NY, 10021, USA.
Grace A StaffordThe Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA.
Vivek KoharThe Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA.
Leonard D ShultzThe Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA.
Michael V WilesThe Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA. michael.wiles@jax.org.
Jackson Laboratory · USHospital for Special Surgery · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymusR01AI132963 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BREHM, MICHAEL ALLEN, MAEHR, RENE · 2017 to 2021
$4.4M
Live imaging of SARS-CoV-2 infection in novel humanized miceR24OD026440 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BREHM, MICHAEL ALLEN, EMERSON, CHARLES P. · 2019 to 2022
$4.2M
Development and Validation of a Novel Cas13a and Nanoparticle Guide-RNA Delivery System that Allows Precise Ablation of Host Macrophage Populations in a Humanized Mouse ModelR21OD027052 · OD · JACKSON LABORATORY · PI WILES, MICHAEL VAN · 2019 to 2020
$480k
NCI NIH HHS P30 CA034196NCI NIH HHS P30CA034196NIAID NIH HHS R01 AI132963NIH HHS R21 OD027052NIH HHS R24 OD026440ODCDC CDC HHS R21 OD027052
6 · The paper itself

Abstract

backgroundGene disruption in mouse embryonic stem cells or zygotes is a conventional genetics approach to identify gene function in vivo. However, because different gene disruption strategies use different mechanisms to disrupt genes, the strategies can result in diverse phenotypes in the resulting mouse model. To determine whether different gene disruption strategies affect the phenotype of resulting mutant mice, we characterized Rhbdf1 mouse mutant strains generated by three commonly used strategies-definitive-null, targeted knockout (KO)-first, and CRISPR/Cas9.

resultsWe find that Rhbdf1 responds differently to distinct KO strategies, for example, by skipping exons and reinitiating translation to potentially yield gain-of-function alleles rather than the expected null or severe hypomorphic alleles. Our analysis also revealed that at least 4% of mice generated using the KO-first strategy show conflicting phenotypes.

conclusionsExon skipping is a widespread phenomenon occurring across the genome. These findings have significant implications for the application of genome editing in both basic research and clinical practice.

Indexed as

ExonsGene ExpressionPhenotypeAdaptation, BiologicalAnimalsCRISPR-Cas SystemsFemaleGene TargetingMaleMembrane ProteinsMiceMice, KnockoutMutationPregnancyMembrane ProteinsRhbdf1 protein, mouseAnd RHBDF1CRISPR/Cas9Definitive-nullExon skippingGene disruptionGene editingKnockout-first

Identifiers

PMID32646486
PMCPMC7350591
OpenAlexW3042013601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.